Mohammad Pasha

Discovery of the Macrocycle 11-(2-Pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a Potent Janus Kinase 2/Fms-Like Tyrosine Kinase-3 (JAK2/FLT3) Inhibitor for the Treatment of Myelofibrosis and Lymphoma

Anthony D. William, Angeline C.-H. Lee, Stéphanie Blanchard et al. · Journal of Medicinal Chemistry · 2011 · 194 citations · Full text

Janus Kinase 2, Pharmacotherapy, Tumor Biology +19

Real-Time Overhead Transmission-Line Monitoring for Dynamic Rating

D.A. Douglass, William A. Chisholm, Glenn Davidson et al. · IEEE Transactions on Power Delivery · 2014 · 140 citations

Real-time Monitoring, Engineering, Measurement +16

Discovery of Kinase Spectrum Selective Macrocycle (16<i>E</i>)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene (SB1317/TG02), a Potent Inhibitor of Cyclin Dependent Kinases (CDKs), Janus Kinase 2 (JAK2), and Fms-like Tyrosine Kinase-3 (FLT3) for the Treatment of Cancer

Anthony D. William, Angeline C.-H. Lee, Kee Chuan Goh et al. · Journal of Medicinal Chemistry · 2011 · 99 citations · Full text

Immunology, Janus Kinase 2, Oral Efficacy +17

Association of IFN-<i>γ</i> : IL-10 Cytokine Ratio with Nonsegmental Vitiligo Pathogenesis

Yaswanth Ala, Mohammad Pasha, Raja Narasimha Rao et al. · Autoimmune Diseases · 2015 · 45 citations · Full text

In Vitro Phase I Cytochrome P450 Metabolism, Permeability and Pharmacokinetics of SB639, a Novel Histone Deacetylase Inhibitor in Preclinical Species

Pilla Reddy Venkatesh, Evelyn Mei Ling Goh, Peizi Zeng et al. · Biological and Pharmaceutical Bulletin · 2007 · 28 citations · Full text

Oral Bioavailability, Pharmacotherapy, Pharmacokinetics +16